Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow CAH
Cardinal Health, Inc. (CAH) Current ratio
Cardinal Health, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 0.9×. Over the past ten years it has ranged from 0.9× (fiscal 2026) to 1.3× (fiscal 2017) — the current reading is the lowest in ten years. That is below the Medical Distribution industry median of 1.1× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 0.9× | (5.60%) |
| FY2025 | 0.9× | (4.46%) |
| FY2024 | 1.0× | (2.11%) |
| FY2023 | 1.0× | (7.25%) |
| FY2022 | 1.1× | (4.08%) |
| FY2021 | 1.1× | 2.32% |
| FY2020 | 1.1× | 2.87% |
| FY2019 | 1.1× | (0.43%) |
| FY2018 | 1.1× | (19.71%) |
| FY2017 | 1.3× | 19.85% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 0.9× | (2.63%) |
| Mar 2026 | 0.9× | 0.09% |
| Dec 2025 | 0.9× | (5.36%) |
| Sep 2025 | 1.0× | 2.34% |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| HKPD Cellyan Biotechnology Co., Ltd compare | 3.9× |
| FOCL FocalTherics compare | 1.6× |
| AHG Akso Health Group Sponsored ADR compare | 1.5× |
| HSIC Henry Schein, Inc. compare | 1.3× |
| COSM Cosmos Health Inc. compare | 1.1× |
| COR Cencora, Inc. compare | 0.9× |
| MCK McKesson Corporation compare | 0.9× |
| CAH Cardinal Health, Inc. | 0.9× |
| ACH Accendra Health, Inc. compare | 0.4× |
| Medical Distribution industry median | 1.1× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on CAH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement